The potential value of a new medicine is not likely to be fully known at the time of marketing approval. New uses can expand both the therapeutic and financial value of a particular medicine. In a new study, OHE Consulting seeks to describe and quantify such value expansion for a cohort of cancer drugs. Read more here. (Source: OHE, 5/13/14).
You are here: / / The Expanding Value Footprint Of Oncology Treatments